These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30869653)

  • 1. New epitopes in ovalbumin provide insights for cancer neoepitopes.
    Karandikar SH; Sidney J; Sette A; Selby MJ; Korman AJ; Srivastava PK
    JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles Vaccines Designed for Enhanced CD8
    Busch E; Kubon KD; Mayer JKM; Pidelaserra-Martí G; Albert J; Hoyler B; Heidbuechel JPW; Stephenson KB; Lichty BD; Osen W; Eichmüller SB; Jäger D; Ungerechts G; Engeland CE
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32098134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a recombinant influenza virus bearing both the CD4+ and CD8+ T cell epitopes of ovalbumin.
    Garulli B; Di Mario G; Sciaraffia E; Kawaoka Y; Castrucci MR
    J Biomed Biotechnol; 2011; 2011():497364. PubMed ID: 22007143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS; Esparon S; Apostolopoulos V; Pietersz GA
    Immunol Cell Biol; 2011 Nov; 89(8):904-13. PubMed ID: 21383765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses.
    Huff AL; Evgin L; Thompson J; Kottke T; Driscoll CB; Tonne J; Wongthida P; Schuelke M; Shim KG; Mer G; Ramirez-Alvarado M; Vile R
    Mol Ther; 2020 Dec; 28(12):2540-2552. PubMed ID: 32877695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
    Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
    Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of cancer neoepitopes needs new rules.
    Brennick CA; George MM; Srivastava PK; Karandikar SH
    Semin Immunol; 2020 Feb; 47():101387. PubMed ID: 31952902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo.
    Jackaman C; Majewski D; Fox SA; Nowak AK; Nelson DJ
    Cancer Immunol Immunother; 2012 Dec; 61(12):2343-56. PubMed ID: 22714286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
    J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.
    Toor JS; Rao AA; McShan AC; Yarmarkovich M; Nerli S; Yamaguchi K; Madejska AA; Nguyen S; Tripathi S; Maris JM; Salama SR; Haussler D; Sgourakis NG
    Front Immunol; 2018; 9():99. PubMed ID: 29441070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses.
    Flechtner JB; Cohane KP; Mehta S; Slusarewicz P; Leonard AK; Barber BH; Levey DL; Andjelic S
    J Immunol; 2006 Jul; 177(2):1017-27. PubMed ID: 16818758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen).
    Goldberg J; Shrikant P; Mescher MF
    J Immunol; 2003 Jan; 170(1):228-35. PubMed ID: 12496404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
    Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
    Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.
    Das K; Eisel D; Vormehr M; Müller-Decker K; Hommertgen A; Jäger D; Zörnig I; Feuerer M; Kopp-Schneider A; Osen W; Eichmüller SB
    BMC Cancer; 2019 Sep; 19(1):914. PubMed ID: 31519152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of homologous rather than heterologous antigen-specific CD4 T cell responses is critical for functional CD8 T cell responses in mice transgenic for a foreign antigen.
    Sabarth N; Chamberlain L; Brett S; Tite J; Craigen J
    J Immunol; 2010 Oct; 185(8):4590-601. PubMed ID: 20861346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.